Delivery Order SPE2DB24D2100-SPE2DB25FBCSW
Award Date 3/12/25
Potential Completion Date 3/13/25
Potential Value $3.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a ceiling value of $1,086.17 and a period of performance through June 11, 2025. The contract is a Firm Fixed Price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567557443 ! LIDOCAINE 5% PATCH 30S, a medical product, and has a ceiling value of $3,112.80. The contract is a Firm Fixed Price, Delivery Order type and has an ultimate completion date of March 13, 2025. This award is not associated with a set-aside designation....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565616944 ! LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $10,010.10 and is a firm fixed price delivery order with an ultimate completion date of August 29, 2024. It is not a set-aside contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,486.40 and is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 12, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $1,397.16 and is a firm fixed-price delivery order with a completion date of May 16, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $4,746.37 and a completion date of March 8, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565546864 LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $14,684.96 and a completion date of August 23, 2024. The contract is a Firm Fixed Price agreement without any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $4,626.25 and a performance period through March 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a ceiling value of $5,251.16 and a period of performance through April 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $7,535.01 firm fixed-price contract is for the delivery of 4565655175 - LIDOCAINE 5% PATCH 30S, a medical supply product. The contract has an ultimate completion date of September 4, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBCSWDelivery Order
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567557566 LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $3,646.35 and an ultimate completion date of March 13, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 7/1/25, 9:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 3/12/25 |